Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT01084902
Eligibility Criteria:
Inclusion Criteria:
1. Diagnosed with POAG or OHT
2. Older than 18 years, either sex
3. With IOP≤30mmHg in both eyes and with IOP\>21mmHg in either eye after washout
4. Understand the study instructions and are willing to attend at all follow-up appointments
5. Be willing to comply with study medication use
6. Ready for written informed consent
Exclusion Criteria:
1. Visual field defects within the central 10°
2. Absence of vision in one eye
3. History of hypersensitivity to any components of the study medications
4. Contraindications to carbonic anhydrase inhibitors or prostaglandins
5. History of ocular herpetic disease, uveitis, or cystoid macular edema
6. Ocular history of trauma, inflammation, surgery or use of corticosteroids (within 2 months)
7. History of ocular laser therapy within 3 months
8. Severe dry eyes
9. Signs of ocular infection, except blepharitis
10. Corneal abnormality that may affect IOP measurements
11. Unwilling to accept the risk for hyperchromia of the iris or development of hypertrichosis
12. Pregnant females or lactating mothers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01084902
Study Brief:
Protocol Section:
NCT01084902